In the preceding three months, 17 analysts have released ratings for Confluent CFLT, presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 7 | 5 | 5 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 4 | 5 | 5 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Confluent, revealing an average target of $32.65, a high estimate of $40.00, and a low estimate of $23.00. Witnessing a positive shift, the current average has risen by 18.13% from the previous average price target of $27.64.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Confluent's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Mike Cikos | Needham | Raises | Buy | $38.00 | $35.00 |
| Brad Reback | Stifel | Announces | Buy | $40.00 | - |
| Gregg Moskowitz | Mizuho | Raises | Buy | $38.00 | $34.00 |
| Matthew Hedberg | RBC Capital | Raises | Outperform | $37.00 | $35.00 |
| Pinjalim Bora | JP Morgan | Raises | Neutral | $27.00 | $23.00 |
| Nick Altmann | Scotiabank | Raises | Sector Perform | $28.00 | $22.00 |
| Raimo Lenschow | Barclays | Raises | Overweight | $33.00 | $26.00 |
| Patrick Walravens | JMP Securities | Raises | Market Outperform | $38.00 | $25.00 |
| Kash Rangan | Goldman Sachs | Raises | Neutral | $27.00 | $24.00 |
| Gregg Moskowitz | Mizuho | Raises | Buy | $34.00 | $29.00 |
| Matthew Hedberg | RBC Capital | Raises | Outperform | $35.00 | $30.00 |
| Michael Turrin | Wells Fargo | Raises | Overweight | $36.00 | $30.00 |
| Mike Cikos | Needham | Raises | Buy | $35.00 | $30.00 |
| Karl Keirstead | UBS | Raises | Neutral | $26.00 | $21.00 |
| Mike Cikos | Needham | Maintains | Buy | $30.00 | - |
| Yun Kim | Loop Capital | Announces | Hold | $23.00 | - |
| Mike Cikos | Needham | Raises | Buy | $30.00 | $23.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Confluent. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Confluent compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Confluent's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Confluent's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Confluent analyst ratings.
About Confluent
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
Confluent's Financial Performance
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Positive Revenue Trend: Examining Confluent's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 26.39% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -44.14%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -11.77%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Confluent's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -3.9%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Confluent's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.37, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: Simplified
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
